Application 211497
- Type
- ANDA
- Sponsor
- TEVA PHARMS USA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PENICILLAMINE | PENICILLAMINE | TABLET;ORAL | 250MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211497-001 | PENICILLAMINE | PENICILLAMINE | 250MG | TABLET / ORAL | 2020-02-13 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A211497-001 | PENICILLAMINE | 250MG | TABLET / ORAL | 2020-02-13 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Penicillamine | PENICILLAMINE | Granules Pharmaceuticals Inc. | f658b20a-269f-4e78-a79b-a56a5ed8dc1b | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | Penicillamine PENICILLAMINE |
| Penicillamine | PENICILLAMINE | Breckenridge Pharmaceutical, Inc. | 1320f46b-e243-4e93-b9c9-ad8eb7828de5 | 2026-08-14 | Boxed warning, Warnings, Adverse reactions | Penicillamine PENICILLAMINE |
| penicillamine | PENICILLAMINE | Par Health USA, LLC | 72ee469c-f9ef-4bb4-922f-5d71276664a5 | 2026-07-31 | Warnings, Adverse reactions | penicillamine PENICILLAMINE |
| Penicillamine | PENICILLAMINE | Par Health USA, LLC | 01e79d8f-8c74-4f48-b761-9f225fabf93d | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | Penicillamine PENICILLAMINE |
| Cuprimine | PENICILLAMINE | Bausch Health US, LLC | 80e736d3-2017-4d68-94b4-38255c3c59c6 | 2026-01-26 | Boxed warning, Warnings, Adverse reactions | PENICILLAMINE |
| Depen | PENICILLAMINE | Viatris Specialty LLC | 38f8ae60-b354-11de-8a39-0800200c9a66 | 2025-09-21 | Boxed warning, Warnings, Adverse reactions | PENICILLAMINE |
| AAGYLUR | PENICILLAMINE | Cycle Pharmaceuticals Ltd. | ddbd84a9-1c39-42e0-a271-138784e1dc58 | 2024-10-01 | Boxed warning, Warnings, Adverse reactions | PENICILLAMINE |
| Penicillamine | PENICILLAMINE | Actavis Pharma, Inc. | 594d7a82-af1d-41c4-98ee-0ea6895fc237 | 2024-09-25 | Boxed warning, Warnings, Adverse reactions | Penicillamine PENICILLAMINE |
| Penicillamine | PENICILLAMINE | Lupin Pharmaceuticals, Inc. | f6ecaf47-902f-4378-b524-7a88f20ba138 | 2022-12-28 | Boxed warning, Warnings, Adverse reactions | Penicillamine PENICILLAMINE |
| Penicillamine | PENICILLAMINE | Navinta LLC | 064fb48d-aa34-4e52-9295-10f2ca4c77dc | 2022-12-02 | Warnings, Adverse reactions | Penicillamine PENICILLAMINE |
| Penicillamine | PENICILLAMINE | Proficient Rx LP | c92335c6-f6fa-4768-9401-55c6b7f87699 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | Penicillamine PENICILLAMINE |
| Penicillamine | PENICILLAMINE | Dr. Reddy's Laboratories Inc. | 15d08594-83a9-cc7a-92ef-1bac0427e121 | 2020-08-05 | Boxed warning, Warnings, Adverse reactions | Penicillamine PENICILLAMINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 62176 | ORIG | 2020-03-17 |